tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Moleculin Biotech (DE:MOL)
:MOL
Germany Market
MOL
Moleculin Biotech
Overview
Analyst Forecasts
News & Insights
Financials
Dividends
Technical Analysis
Chart
Earnings
Historical Prices
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Moleculin Biotech (MOL) Stock News & Sentiment

Compare
2 Followers
Moleculin, CNS, Global-e, Tenet, Summit: Trending by Analysts
Premium
Weekend Updates
Moleculin, CNS, Global-e, Tenet, Summit: Trending by Analysts
2d ago
THC
CNSP
Moleculin Biotech’s Promising Earnings Call Highlights
Premium
Company Announcements
Moleculin Biotech’s Promising Earnings Call Highlights
6d ago
MBRX
Moleculin Biotech Advances Clinical Trials Amid Financial Losses
Premium
Company Announcements
Moleculin Biotech Advances Clinical Trials Amid Financial Losses
6d ago
MBRX
Promising Advancements in Moleculin Biotech’s Annamycin Pivotal Trial Drive Buy Rating and $8 Price Target
Premium
Ratings
Promising Advancements in Moleculin Biotech’s Annamycin Pivotal Trial Drive Buy Rating and $8 Price Target
7d ago
MBRX
Moleculin Biotech Shares Corporate Presentation Update
Premium
Company Announcements
Moleculin Biotech Shares Corporate Presentation Update
7d ago
8K
MBRX
MBRX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
MBRX Upcoming Earnings Report: What to Expect?
13d ago
MBRX
Buy Rating for Moleculin Biotech: Accelerated Annamycin Development and Strategic Advancements
Premium
Ratings
Buy Rating for Moleculin Biotech: Accelerated Annamycin Development and Strategic Advancements
28d ago
MBRX
More DE:MOL News >

MOL News on the Web

All You Need to Know About Moleculin Biotech (MBRX) Rating Upgrade to Buy
Zacks
Bullish
Moleculin Biotech Inc (MBRX) Q4 2024 Earnings Call Highlights: Promising Clinical Trials and ...
GuruFocus News
Neutral
Q4 2024 Moleculin Biotech Inc Earnings Call Transcript
GuruFocus News
Neutral
Moleculin Biotech Inc Reports Q4 Earnings: EPS of -$1. ...
GuruFocus News
Bullish
Moleculin Biotech, Inc. Participates in the Virtual Investor On-Demand Conference
Yahoo Finance
Neutral
Moleculin to Present at the 37th Annual ROTH Conference
Yahoo Finance
Neutral
Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity
Yahoo Finance
Neutral
Moleculin Biotech target adjusted to $8 from $45 at H.C. Wainwright
The Fly
Neutral

News Score - Last 7 Days

Positive
DE:MOL
Sector Average
Media Buzz
This Week4 articles
Weekly Average2 articles
News Sentiment
This Week99%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:MOL’s Media Buzz Sentiment?
4 articles about DE:MOL were published this week. In an average week, 2 articles are published.
    What is DE:MOL’s weekly average amount of articles?
    In an average week, 2 articles about DE:MOL are published.
      What is DE:MOL’s News Sentiment?
      99% of articles about DE:MOL were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        SLNOSoleno Therapeutics
        ALCAlcon
        DYAIDyadic International
        CLGNCollplant Holdings
        GRDNGuardian Pharmacy Services, Inc. Class A
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing